Tapinarof is a topical aryl hydrocarbon receptor agonist used to treat plaque psoriasis and atopic dermatitis. To support the rigorous quality control and safety requirements of this medication, laboratories… Read more













Tapinarof is a topical aryl hydrocarbon receptor agonist used to treat plaque psoriasis and atopic dermatitis. To support the rigorous quality control and safety requirements of this medication, laboratories rely on high-quality reference standards, including the active pharmaceutical ingredient, potential process-related impurities, synthetic intermediates, and degradation products. Impurity profiling is critical during method validation and stability testing to ensure therapeutic efficacy and regulatory compliance. Additionally, stable isotope-labelled compounds serve as internal standards for sensitive analytical techniques like mass spectrometry, allowing for accurate quantification in complex matrices. Whether developing new analytical methods or performing routine batch release, these structurally characterized materials, including pharmacopeial and non-pharmacopeial impurities, are essential for characterizing the chemical profile of this therapy throughout its lifecycle.